Fosomax for Osteoporosis

Image by Tom Varco

Taking Fosomax for Osteoporosis - An Overview

Fosomax, known as alendronate generically, is a powerful FDA approved osteoporosis medication. Osteoporosis, which literally means, porous bones, is a serious degenerative disease that currently affects 1 in 5 American women who are 50 years old or older. Fosomax is designed to address the steady and incremental bone loss that occurs in patients suffering from osteoporosis by inhibiting the action of osteoclasts, which are specialized bone cells that work to break down bone to allow their minerals to be reabsorbed by the bloodstream.

Fosomax has been shown, in two clinical safety studies lasting 3 years each, to be generally well tolerated by post-menopausal women, a population at exceptionally high risk for developing osteoporosis and related bone density disorders.

However, all patients currently taking fosomax, or currently considering making fosomax their osteoporosis medication, should be well aware of the potential risks and complications associated with the drug. No compound is entirely safe and without risks or potential interactions. Arming yourself and your family with knowledge of fosomax's safety profile will help you stay ahead of any potentially serious complications before they advance too far. As always, working closely with your primary health care provider to manage your health and monitor your use of osteoporosis medication will help to reduce the overall risk of your treatment regimen.

Fosomax as an Osteoporosis Medication

Fosomax belongs to a family of osteoporosis medication known as bisphosphonates, which are generally administered to sufferers of osteoporosis and / or bone cancer. Fosomax comes in two major varieties: fosomax alone, and fosomax which has had calcium and vitamin D, two compounds essential to good bone health, chemically added to it.

Depending upon your age, your bone density mass ( a measurement of the hardness and overall health of your skeleton) and your other medications and conditions, your doctor may choose to prescribe you either daily smaller doses of fosomax as your osteoporosis medication, or a larger once weekly dose of fosomax.

Fosomax is known amongst doctors and pharmacists for its low bioavailability. Bioavailability refers to the chemically active amount of a swallowed or injected dose that can act upon the body. The remainder of a dose of osteoporosis medication that is not bioavailable is either metabolized, destroyed, and / or excreted by other body systems before it can act upon the body. While the bioavailability of their osteoporosis medication is not of much concern to most patients, it is important to understand that many commonly taken and easily available over the counter treatments can exert potentially profound effects on your dose of fosomax. For example, ranitidine, which is found in many different over the counter treatments for heartburn and acid reflux, can increase the bioavailability of fosomax, and therefore its potency.

Fosomax is also known for its long half-life as an osteoporosis medication. A compound's half-life refers to the amount of time it is capable of exerting a chemical effect on the body. Fosomax's long half-life allows it to work cumulatively to preserve bone mass and bone mineral density in patients taking it over long periods as their primary osteoporosis medication. This is beneficial in the sense that it can work progressively to protect bone mass in patients that are tolerating their osteoporosis medication well. However, this same aspect also opens Fosomax up to scrutiny regarding its potential long-term side effects as an osteoporosis medication, which, as of today, are still poorly understood.